Wunder F - Search Results

1

A novel PDE2A reporter cell line: characterization of the cellular activity of PDE inhibitors.

Wunder F, Gnoth MJ, Geerts A, Barufe D. Wunder F, et al. Mol Pharm. 2009 Jan-Feb;6(1):326-36. doi: 10.1021/mp800127n. Mol Pharm. 2009. PMID: 19049345

2

Generation and characterization of a stable soluble guanylate cyclase-overexpressing CHO cell line.

Becker EM, Wunder F, Kast R, Robyr C, Hoenicka M, Gerzer R, Schröder H, Stasch JP. Becker EM, et al. Among authors: wunder f. Nitric Oxide. 1999;3(1):55-66. doi: 10.1006/niox.1999.0207. Nitric Oxide. 1999. PMID: 10355896

3

A cell-based cGMP assay useful for ultra-high-throughput screening and identification of modulators of the nitric oxide/cGMP pathway.

Wunder F, Stasch JP, Hütter J, Alonso-Alija C, Hüser J, Lohrmann E. Wunder F, et al. Anal Biochem. 2005 Apr 1;339(1):104-12. doi: 10.1016/j.ab.2004.12.025. Anal Biochem. 2005. PMID: 15766716

4

Characterization of the first potent and selective PDE9 inhibitor using a cGMP reporter cell line.

Wunder F, Tersteegen A, Rebmann A, Erb C, Fahrig T, Hendrix M. Wunder F, et al. Mol Pharmacol. 2005 Dec;68(6):1775-81. doi: 10.1124/mol.105.017608. Epub 2005 Sep 8. Mol Pharmacol. 2005. PMID: 16150925

5

A cell-based nitric oxide reporter assay useful for the identification and characterization of modulators of the nitric oxide/guanosine 3',5'-cyclic monophosphate pathway.

Wunder F, Buehler G, Hüser J, Mundt S, Bechem M, Kalthof B. Wunder F, et al. Anal Biochem. 2007 Apr 15;363(2):219-27. doi: 10.1016/j.ab.2007.02.001. Epub 2007 Feb 4. Anal Biochem. 2007. PMID: 17336915

6

Pharmacological and kinetic characterization of adrenomedullin 1 and calcitonin gene-related peptide 1 receptor reporter cell lines.

Wunder F, Rebmann A, Geerts A, Kalthof B. Wunder F, et al. Mol Pharmacol. 2008 Apr;73(4):1235-43. doi: 10.1124/mol.107.042283. Epub 2008 Jan 3. Mol Pharmacol. 2008. PMID: 18174292

7

Pharmacological characterization of the first potent and selective antagonist at the cysteinyl leukotriene 2 (CysLT(2)) receptor.

Wunder F, Tinel H, Kast R, Geerts A, Becker EM, Kolkhof P, Hütter J, Ergüden J, Härter M. Wunder F, et al. Br J Pharmacol. 2010 May;160(2):399-409. doi: 10.1111/j.1476-5381.2010.00730.x. Br J Pharmacol. 2010. PMID: 20423349 Free PMC article.

8

Chemosensory Ca2+ dynamics correlate with diverse behavioral phenotypes in human sperm.

Veitinger T, Riffell JR, Veitinger S, Nascimento JM, Triller A, Chandsawangbhuwana C, Schwane K, Geerts A, Wunder F, Berns MW, Neuhaus EM, Zimmer RK, Spehr M, Hatt H. Veitinger T, et al. Among authors: wunder f. J Biol Chem. 2011 May 13;286(19):17311-25. doi: 10.1074/jbc.M110.211524. Epub 2011 Mar 21. J Biol Chem. 2011. PMID: 21454470 Free PMC article.

9

Luteinizing hormone reduces the activity of the NPR2 guanylyl cyclase in mouse ovarian follicles, contributing to the cyclic GMP decrease that promotes resumption of meiosis in oocytes.

Robinson JW, Zhang M, Shuhaibar LC, Norris RP, Geerts A, Wunder F, Eppig JJ, Potter LR, Jaffe LA. Robinson JW, et al. Among authors: wunder f. Dev Biol. 2012 Jun 15;366(2):308-16. doi: 10.1016/j.ydbio.2012.04.019. Epub 2012 Apr 21. Dev Biol. 2012. PMID: 22546688 Free PMC article.

10

Pharmacological characterization of receptor guanylyl cyclase reporter cell lines.

Wunder F, Woermann A, Geerts A, Milde M. Wunder F, et al. Eur J Pharmacol. 2013 Jan 5;698(1-3):131-6. doi: 10.1016/j.ejphar.2012.11.009. Epub 2012 Nov 21. Eur J Pharmacol. 2013. PMID: 23178524

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

50 results

Search Page